The balance of the impeller-driver magnet affects the antithrombogenicity in the Gyro permanently implantable pump.
The Gyro permanently implantable (PI) pump is activated magnetically when a double pivot bearing supported impeller is rotated at predetermined revolutions per minute (rpm). The male bearing shaft of the impeller is supported by the top and bottom female pivot bearing in a loosely mated fashion. The Gyro PI pump's impeller transfers to a floating condition when the rpm is increased. The design objective of the Gyro PI pump is to drive the impeller while maintaining a top contact position to prevent thrombus formation. As a left ventricular assist device (LVAD), the Gyro PI pumps achieved long-term survivals in calves without thrombus formation. However, thrombus formation occurred during a biventricular assist device (BVAD) implantation. Our hypothesis was that the impeller remaining in the bottom contact position during the BVAD experiment caused this thrombus formation. Therefore, a replica of the Gyro PI pump housing was fabricated from a transparent plastic to observe the floating conditions of the impeller. When simulating an LVAD animal experiment, the impeller was at a non-bottom contact position. However, when simulating the BVAD animal experiment, the impeller remained at the bottom contact position. This study shows that the magnet balance affects the antithrombogenicity in a Gyro PI pump.
Ichikawa
Seiji
S
Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA.
Nishimura
Ikuya
I
Mikami
Minoru
M
Nonaka
Kenji
K
Linneweber
Joerg
J
Kawahito
Shinji
S
Motomura
Tadashi
T
Ishitoya
Hiroshi
H
Glueck
Julia
J
Shinohara
Toshiyuki
T
Nosé
Yukihiko
Y
D000818:Animals; D001783:Blood Flow Velocity / Q000502:physiology; D002318:Cardiovascular Diseases / Q000503:physiopathology* / Q000628:therapy*; D004195:Disease Models, Animal; D004867:Equipment Design; D005260:Female; D006353:Heart-Assist Devices / Q000009:adverse effects*; D006801:Humans; D008280:Magnetics / Q000627:therapeutic use*; D008297:Male; D008955:Models, Cardiovascular; D013927:Thrombosis / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control*; D013997:Time Factors